Literature DB >> 31092397

Fifteen-minute consultation: Efficient investigation of the child with early developmental impairment in the era of genomic sequencing.

Thomas Coysh1, Sarah Louise Hogg2, Alasdair Pj Parker3.   

Abstract

The investigation of children with early developmental impairment (EDI) is challenging in terms of selecting investigations and supporting families through the diagnostic pathway. Modern genomic sequencing has the potential to greatly improve yield of investigation, but produces challenges in terms of timing and explaining its strengths/weaknesses to families. We present an evidence-based and practical guideline to help the paediatrician through all stages of investigation. We emphasise the importance of a really good history and examination, allowing targeted investigation for specific disorders and outline an approach for isolated EDI when this is not possible. This prioritises genetic investigation- after appropriate counselling to families, and balances the very low yield of biochemical/radiological investigations in isolated EDI, with the need to detect extremely rare, but potentially treatable disorders. Collaboration with both families and regional specialists to ensure appropriate testing is likely to reduce parental and clinician anxiety. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  investigation

Year:  2019        PMID: 31092397     DOI: 10.1136/archdischild-2018-315123

Source DB:  PubMed          Journal:  Arch Dis Child Educ Pract Ed        ISSN: 1743-0585            Impact factor:   1.309


  2 in total

1.  How paediatricians investigate early developmental impairment in the UK: a qualitative descriptive study.

Authors:  Mark Atherton; Anthony R Hart
Journal:  BMC Pediatr       Date:  2022-05-16       Impact factor: 2.567

2.  Genomic Investigation of Infantile and Childhood Epileptic Encephalopathies in Kazakhstan: An Urgent Priority.

Authors:  Altynshash Jaxybayeva; Alissa Nauryzbayeva; Assem Khamzina; Meruert Takhanova; Assel Abilhadirova; Anastasia Rybalko; Kymbat Jamanbekova
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.